EY Greece's George Mitropoulos outlines some of the key challenges and opportunities for both local manufacturers and multinational innovators in…

Rémy Levastre leads professional services firm WSP’s healthcare advisory services in the Middle East. Drawing on a diverse set of professional…

Drawing on the findings of EY's recently published life sciences M&A firepower report, EY Global Life Sciences Deals Leader Subin Baral makes the…

Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by…

Dr Tina Hahn explains how AXON positions itself as a strategic partner for its Danish clients in their scientific communication work, highlights how…

EY’s Abhay Bangi highlights the key trends across the ASEAN life sciences space, how the COVID-19 pandemic has accelerated them, and charts…

Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing…

Jens Ewert, Life Science and Health Care Industry Leader at Deloitte China, shares his perspectives on the growth of China’s Life Sciences and…

When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain…

Mike Braun, partner at Deloitte China, shares his perspectives on the recent China reforms, the strong presence of Deloitte within China as a…

Limaris Alvarado, business director of PharmaLex Puerto Rico (formerly ECHO Consulting Group), started ECHO Consulting Group to enhance and maintain…

The Pharmaceutical Strategy Institute (PSI) is a Korean consulting firm helping local biotech companies reach success by providing strategic and legal…